Oral Cancer

$3.6M grant to study oral cancer saliva detection test
By Melissa Busch
The Moffitt Cancer Center in Florida has received a $3.6 million grant to evaluate an oral gargle test that could be used to screen for oropharyngeal cancer during routine dental checkups.
December 11, 2023
Woman Lab Microscope
Guardant set to present research data at ESMO 2022
By LabPulse.com staff writers
An oral presentation and posters will share how the company's blood tests are utilized in cancer therapy trials, for predicting and monitoring treatment response in patients, and for identifying the genomic mechanisms of acquired resistance in cancer therapy, according to Guardant.
September 5, 2022
2019 08 26 19 10 2762 Lab Blood Man 400
Viome launches early detection test for oral and throat cancers
By LabPulse.com staff writers
The test leverages mRNA technology and an artificial intelligence platform to detect biomarkers for oral and throat cancer with 95% specificity and 90% sensitivity rates, the firm said.
August 3, 2022
2017 09 14 23 05 1167 Cancer Cell 400
AI can lend a hand in diagnosis, prognosis of oral SCC
By Erik L. Ridley
After reviewing published studies in the literature on the use of AI with pathology and radiology images in patients with oral SCC, researchers from the University of Hong Kong concluded that the technology yielded good classification accuracy.
August 18, 2021
2021 08 18 23 12 2135 Computer Ai Artificial Illustration 400
Viome's screening tool given 'breakthrough device' designation
By LabPulse.com staff writers
Viome's technology and AI platform is designed to screen for oral cancer and throat cancer, which are traditionally diagnosed manually by a primary care clinician by visual or tactile senses in a subjective way, often going undiscovered.
May 6, 2021
2021 05 07 15 54 4936 Pharmaceutical Artificial Intelligence 400
Researchers get $3.3M to study AI in oral cancer
By LabPulse.com staff writers
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
2020 03 24 20 53 4672 Dollar Sign Golden 400
ArcherDX teams with Ayala on companion tests
By LabPulse.com staff writers
The deal will involve the application of ArcherDX's proprietary Anchored Multiplexed PCR (AMP) platform to detect mutations in cancers targeted by drugs in Ayala's pipeline. Ayala's focus is on the development of oral gamma secretase inhibitors for cancers driven by the activation of the Notch signaling pathway. Gamma secretase is an enzyme that activates the Notch pathway, leading to tumorigenesis.
July 7, 2019
2019 07 08 18 08 5459 Men Working Business 400
Page 1 of 1